packageAsparaginase

asparaginase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Asparaginase is an enzyme medication used as an anticancer drug to treat lymphoma and lymphoid leukemia. It is an approved medicine, included on the WHO list of essential medicines, and is authorised in the European Union for precursor cell lymphoblastic leukemia-lymphoma.

Summary written by glm-5.3-flash from Wikidata Q105296036 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:asparaginase
ATC codes:L01XX02, LX1XX02
DrugBank:DB00023
Wikidata:Q105296036

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown